Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients

NCT00997022 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Cancer

Interventions

DRUG: Sorafenib

Sponsor

Columbia University

Collaborators

[object Object]
[object Object]